Why the study?
Does rt-PA therapy improve symptoms without hemorrhagic complications in an acute stroke patient taking dabigatran?
Does rt-PA therapy improve symptoms without hemorrhagic complications in an acute stroke patient taking dabigatran?
Administration of rt-PA may be feasible in acute stroke patients on dabigatran when taking into account the APTT and time from the last dose.
No takes yet. Share an insight, caveat, or question.
May support rt-PA feasibility in selected dabigatran patients; leaves open need for prospective validation.
Tabata et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: